As expected, the U.S. House of Representatives yesterday (Jan. 11) passed legislation to extend Federal research funding to newly derived stem cell lines. But while the vote (253 to 174) gained 15 affirmative votes over an identical effort in the last session of Congress, it still fell far short of the two-thirds necessary to over-ride an expected presidential veto."We brought this legislation back for a vote today to give President Bush another chance to do the right thing," Rep. Diana DeGette (D-Colo.), the bill's cosponsor, told reporters after the House vote.The "Stem Cell Research Enhancement Act of 2007" (HR 3/S 5) is identical to a bill that Congress passed, and President Bush vetoed (his first and only veto), in July 2006. Yesterday Bush promised to veto the bill again. Still, supporters were heartened that the bill earned more votes than it did when first passed in 2005. "It's an...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?